Because money and time are often in short supply during product development, we employ creative epidemiologic study designs leveraging existing data sources to demonstrate the validity of your product in real time.
Even if you’ve proven that your product is effective in the clinical trial setting, does it have a place in real-world clinical decision making? We design comparative effectiveness and clinical decision analyses to demonstrate clinical utility of novel pharmaceutical and diagnostic products.
Allow our health economics experts to demonstrate that the value of your product aligns with its costs. We design custom health economics and outcomes studies that quantify cost savings from the payer or health system’s point of view.
SRP LLC team to collaborate with staff of the Injury Surveillance Program, Massachusetts Department of Public Health, on a project linking crash injury data with hospitalization claims dataAug 18, 2016
SRP CEO Catherine Rahilly-Tierney to present a poster at the 86th Annual Meeting of the American Thyroid Association in Denver, CO, September 23, 2016: “Review of Studies Evaluating the Diagnostic Accuracy of the Afirma Gene Expression Classifier in Indeterminate Thyroid Nodules”Jul 21, 2016
SRP team to execute a review and meta-analysis of the performance and utility of Veracyte, Inc.’s proprietary diagnostic testJan 22, 2016